FDA OKs First Rifabutin-Based H Pylori Therapy Talicia FDA OKs First Rifabutin-Based H Pylori Therapy Talicia
Talicia combines omeprazole, amoxicillin, and rifabutin and is designed to address growing bacterial resistance to standard clarithromycin-based H pylori therapy.FDA Approvals
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Infectious Diseases News Alert Source Type: news
More News: Amoxicillin | Biaxin | Clarithromycin | Helicobacter Pylori | Infectious Diseases | Intensive Care | Omeprazole | Prilosec